Published on April 7, 2026
Bayer, a prominent player in the life sciences sector, is making its sixth consecutive appearance at the China International Import Expo (CIIE) with a renewed commitment to its corporate mission of “Health for All, Hunger for None.” This year, the company is showcasing its diverse range of offerings across three major divisions: pharmaceuticals, consumer health, and radiology.
The theme of Bayer’s participation, “Science for Better,” encapsulates the company’s dedication to leveraging scientific advancements to improve lives globally. With an increasing emphasis on innovation, Bayer aims to address some of the world’s most pressing health and nutrition challenges through cutting-edge technologies and solutions.
At the expo, Bayer’s pharmaceuticals division will highlight its research-driven approach to combating diseases and improving patient outcomes. This includes a showcase of transformative therapies that target critical health issues, from oncology to cardiology. The division’s focus on precision medicine emphasizes Bayer’s commitment to delivering tailored treatments that cater to individual patient needs.
The consumer health segment is set to feature a range of well-known brands that promote wellness and preventive care. Bayer aims to educate consumers about the importance of health management and the role of over-the-counter products in maintaining a healthy lifestyle. Engaging sessions and interactive displays will provide insights into how these products can empower individuals to take charge of their health.
In the realm of radiology, Bayer is expected to present its advanced imaging solutions designed to enhance diagnostic accuracy and patient care. The integration of artificial intelligence and other technologies into radiology is transforming how medical professionals approach diagnostics, and Bayer is at the forefront of these innovations.
As the CIIE continues to serve as a pivotal platform for international trade and collaboration, Bayer’s return underscores the company’s long-term commitment to the Chinese market. With China being a key region for growth, Bayer is eager to deepen its partnerships and expand its impact on health and nutrition.
Overall, Bayer’s participation in CIIE this year reinforces its vision of a healthier future through science and innovation. The company’s dedication to addressing global health challenges reflects its ongoing mission to improve the quality of life for people around the world.
Related News
- 4/6: CBS Evening News
- Who wins what in the EU's new trade deal with Australia?
- A Double Bout of Amnesia: Love Letters and The Groundstar Conspiracy
- Huge crowds gather to watch Artemis II launch
- Blue Tigers delight the faithful with a great win
- Early tour bookings surge for 2026 Hùng Kings and April 30 holidays